Scholar Rock
Director, National Accounts (Northeast)
TLDR
The Director, National Accounts will drive the launch of Scholar Rock’s apitegromab, establishing key payer relationships and achieving rapid patient access to this critical therapy.
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Summary of Position:
The Director, National Accounts role is an opportunity for an experienced payer account executive to help launch apitegromab, Scholar Rock’s investigational drug for the treatment of Spinal Muscular Atrophy (SMA). This team will have a direct impact on our ability to deliver value to patients and the trajectory of the company’s first launch. This role will be accountable for establishing Scholar Rock’s presence with key payers, achieving rapid, appropriate coverage for apitegromab in assigned accounts and regions, and supporting ongoing patient access efforts through launch.
Position Responsibilities:
Candidate Requirements:
- Lead account planning, management, and engagement activities at assigned payers to achieve rapid and clinically appropriate access for patients. This includes establishing and further developing relationships with decision makers at key customers
- Support development of apitegromab’s value proposition and other supporting materials, including any account-specific needs
- Maintain a strong understanding of apitegromab Commercial objectives and how to help achieve these goals through assigned accounts
- Work across teams to ensure patient access objectives are met, including pull-through
- Ensure all programs are aligned to Scholar Rock values and remain compliant with regulations
- Lead presence with target accounts at access-related meetings, events and congresses (e.g., AMCP, PCMA, Asembia, Medicaid meetings, etc)
- Collaborate with Insights and Analytics and Commercial Operations to derive account-level insights and actions; communicate access and coverage performance regularly to internal stakeholders
- Proactively identify and execute against opportunities to improve patient access to care, within and outside of Value & Access
- Be a content expert on relevant industry trends, market dynamics, policy and legislation and define implications and actions for Scholar Rock
- Be a collaborative, strategic market access presence throughout the Scholar Rock organization
- Bachelors degree
- At least 6 years’ experience in US Market Access with a deep understanding of evolving access, coverage, and reimbursement landscape
- Experience and relationships with national and key regional Commercial, Medicaid, and other Government payers. Experience with VA/DoD/Tricare and Humana are strongly encouraged
- Proven track record of achieving rapid, broad, and clinically appropriate coverage for medical benefit and/or rare disease products at launch
- Comprehensive understanding of payer decision making bodies and cycles, processes/procedures, and data and reporting
- Experience negotiating agreements with large healthcare systems preferred
- Pre-launch experience at a small, start-up biotechnology company preferred
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Scholar Rock is a biopharmaceutical company dedicated to discovering and developing innovative therapies for patients with serious diseases that lack effective treatment options. By specializing in the biology of the transforming growth factor beta (TGFβ) superfamily of proteins, we are positioned to create groundbreaking treatments that address significant unmet medical needs across multiple conditions, including neuromuscular diseases and cancer.
- Founded
- Founded 2012
- Employees
- 51-200 employees
- Industry
- Biotechnology
- Total raised
- $100M raised